Sectors
CELZ
Creative Medical Technology Holdings, Inc.
1.24
1 x 1.24
1 x 1.29
bid
ask
+
0.04
3.33%
100 @ 04:00 PM
1.30 +0.06 (4.84%)
| Ytd | -36.73% | |
| 1y | -57.53% |
1.20
day range
1.46
0.62
52 week range
6.25
| Open | 1.20 | Prev Close | 1.20 | Low | 1.20 | High | 1.46 | Mkt Cap | 3.20M |
| Vol | 3.01M | Avg Vol | 9.52M | EPS | -2.14 | P/E | -0.58 | Forward P/E | -0.84 |
| Beta | 1.94 | Short Ratio | 0.56 | Inst. Own | 3.96% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 1.39 | 200-d Avg | 2.08 | 1yr Est | 30.00 |
| Income Statement | |||
| Operating Expenses | 1.56M | ||
| Research and Development Expense | 459.20K | ||
| Selling, General and Administrative Expense | 1.08M | ||
| Operating Income | -1.56M | ||
| Net Income | -1.51M | ||
| Net Income Common Stock | -1.51M | ||
| Net Income Common Stock (USD) | -1.51M | ||
| Consolidated Income | -1.51M | ||
| Net Income to Non-Controlling Interests | 726.00 | ||
| Earnings per Basic Share | -0.41 | ||
| Earnings per Basic Share (USD) | -0.41 | ||
| Earnings per Diluted Share | -0.41 | ||
| Earning Before Interest & Taxes (EBIT) | -1.51M | ||
| Earning Before Interest & Taxes (USD) | -1.51M | ||
| Weighted Average Shares | 3.70M | ||
| Weighted Average Shares Diluted | 3.70M | ||
| Balance Sheet | |||
| Cash and Equivalents | 8.71M | ||
| Cash and Equivalents (USD) | 8.71M | ||
| Investments | 234.34K | ||
| Investments Current | 234.34K | ||
| Current Assets | 9.02M | ||
| Total Assets | 9.38M | ||
| Debt Current | 14.19K | ||
| Total Debt | 14.19K | ||
| Current Liabilities | 698.60K | ||
| Total Liabilities | 698.60K | ||
| Accumulated Retained Earnings (Deficit) | -73.50M | ||
| Shareholders Equity | 8.68M | ||
| Shareholders Equity (USD) | 8.68M | ||
| Assets Non-Current | 358.74K | ||
| Total Debt (USD) | 14.19K | ||
| Goodwill and Intangible Assets | 355.46K | ||
| Trade and Non-Trade Payables | 684.40K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 22.92K | ||
| Net Cash Flow from Financing | 4.46M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 2.99M | ||
| Issuance (Purchase) of Equity Shares | 4.46M | ||
| Net Cash Flow from Operations | -1.47M | ||